San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

Hims & Hers' stock price has swung wildly this year. The telehealth company's public feud with drugmaker Novo Nordisk knocked off a nearly a third of its valuation on Monday. On Friday, Hims ...

Hims & Hers’ stock price has swung wildly this year. The price had at one point soared more than 150% this year before the Novo split knocked off a nearly a third of its valuation on Monday.

Hims & Hers Health, Inc. sees 38% YoY subscriber growth, driven by 70% choosing personalized treatments. Click for my updated look at HIMS stock prospects.

The move will rapidly expand Hims & Hers’ reach, which has a current base of 2.4 million U.S. customers. As the only digital health company with over a decade of operations across Germany ...

In the current session, the stock is trading at $53.36, after a 1.12% spike. Over the past month, Hims & Hers Health Inc. HIMS stock increased by 8.11%, and in the past year, by 159.83%. With ...

The stock price for Hims & Hers Health (NYSE: HIMS) is $47.49 last updated July 3, 2025 at 8:15 AM EDT.

The move will rapidly expand Hims & Hers’ reach, which has a current base of 2.4 million U.S. customers. As the only digital health company with over a decade of operations across Germany ...

Citi is holding firm on its Sell rating for Hims & Hers Health, Inc. (NYSE: HIMS), according to a report released on June 3, keeping a $30 price target even as the company moves to expand its ...